Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), sold 3,958 shares at $3.39 ($13K) on 2022-08-26, disclosed to the SEC on 2022-09-09.
Open-market sale of $13k BRTX by VP of Research and Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |